Research analysts at StockNews.com started coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Get Rating) in a report issued on Wednesday. The brokerage set a “sell” rating on the stock. Separately, HC Wainwright dropped their target price on shares of Galectin Therapeutics from $14.00 to $11.00 and set a “buy” rating on the stock in […]
Galectin Therapeutics Inc. (NASDAQ:GALT – Get Rating) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.68 and traded as high as $2.17. Galectin Therapeutics shares last traded at $2.07, with a volume of 56,882 shares traded. Wall Street Analysts Forecast Growth GALT has been […]
The city of Galt has a new crime-fighting tool called the Flock Safety System, which has been in place for two months and is already helping victims get back their stolen items.
Galectin Therapeutics (NASDAQ:GALT – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Galectin Therapeutics Inc. is a drug development company engaged in the development new therapies for fibrotic disease and cancer. The Company uses its carbohydrate […]